Our Best Shot - CHI’s Mandatory COVID-19 Vaccination Policy

To ensure maximum safety, CHI has instituted a mandatory COVID-19 vaccination policy for all in-person participants across all our events. We feel it is our community duty to ensure CHI events are part of the COVID-19 solution to reopening safely. We are confident the scientific community, which developed the vaccine, will rally behind us on this first-of-its-kind policy.

OPT Congress is now Back In-Person

OPT Congress provides a unique opportunity to discuss advances in next-generation oligonucleotide therapies throughout the drug development process. We bring together leading discovery and development scientists, CMC and regulatory experts, and technology providers, to help you optimize drug design and delivery, streamline manufacturing and regulatory issues and accelerate time to market.

Conference Programs

Add Dates to Outlook

Past Keynote Speakers Include:

Bob Brown, PhD

Melissa J. Moore, PhD
CSO, Moderna

Muthiah (Mano) Manoharan, PhD

Muthiah (Mano) Manoharan, PhD
Senior Vice President, Drug Discovery, Alnylam Pharmaceuticals

Richard S. Geary, PhD

Richard S. Geary, PhD
Executive Vice President (EVP), Drug Development, Ionis Pharmaceuticals

Phil Baran, PhD

Phil Baran, PhD
Chair & Professor, Chemistry, Scripps Research Institute

Laura Sepp-Lorenzino, PhD

Sepp-Lorenzino, PhD

CSO, Intellia Therapeutics

Bob Brown, PhD

Bob Brown, PhD
CSO and Executive Vice President R&D, Dicerna Pharmaceuticals

With thanks to our Executive Advisory Board

Dmitry Samarsky, PhD
CTO, Sirnaomics

Muthiah (Mano) Manoharan, PhD
Senior Vice President, Drug Discovery, Alnylam Pharmaceuticals

Arthur Levin, PhD
Executive Vice President, Research and Development, Avidity Biosciences

Lubo Nechev, PhD
Vice President Process and Analytical Sciences, Alnylam Pharmaceuticals

Ekkehard Leberer, PhD
Senior Life Sciences Consultant, ELBIOCON


Email us at:


Ready to Register?

Secure your space now